We enable reproducible, scalable genetic engineering through our ExPERT™ platform, built on clinically proven Flow Electroporation® technology and engineered to perform from discovery through GMP manufacturing. Our SeQure™ genotoxicity services complement delivery with rigorous safety and integration assessment, helping teams generate the evidence needed to derisk programs and support regulatory decision-making.
MaxCyte® partners with innovators in cell therapy,  biologics, and drug discovery to navigate the complex path from discovery to clinical manufacturing.
We enable reproducible, scalable genetic engineering through our ExPERT™ platform, built on clinically proven Flow Electroporation® technology and engineered to perform from discovery through GMP manufacturing. Our SeQure™ genotoxicity services complement delivery with rigorous safety and integration assessment, helping teams generate the evidence needed to derisk programs and support regulatory decision-making.
By combining delivery and validation in a platform trusted from bench to clinic, we help teams move faster with confidence—so proven innovation reaches patients sooner. Built for innovation. Measured in lives changed.